Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 100 Fast-growings companies in Monoclonal antibody
by Most Patent Filing In 3 Years in the China in 2018

The Monoclonal antibody top 100 is Discovery PatSnap’ annual ranking of the top 100 Most Patent Filing In 3 Years Monoclonal antibody Fast-growings in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.
#
Company Name
Region
Tech Topics
Total
1
Patent: 88
2
Patent: 47
3
Pinyin,Educational institution,Cancer immunotherapy,
...[+2]
Patent: 32
4
Patent: 29
5
Patent: 26
6
Patent: 24
7
Patent: 22
8
Agronomy,Basic science,Agricultural science,
...[+2]
Patent: 19
9
Patent: 18
10
Pinyin,Mainland China,Social science,
...[+2]
Patent: 17
11
Patent: 16
12
Pinyin,Coronavirus,Jurisdiction,
...[+2]
Patent: 16
13
Patent: 16
14
Patent: 16
15
Patent: 16
16
Medicine,Health care,Immunoassay,
...[+2]
Patent: 16
17
CONTEST,Biological membrane,Biofabrication,
...[+2]
Patent: 14
18
Patent: 14
19
Patent: 14
20
Patent: 14
21
Pinyin,Social science,Educational institution,
...[+2]
Patent: 13
22
Patent: 13
23
Patent: 13
24
Patent: 13
25
Patent: 12
26
Patent: 12
27
Patent: 12
28
Medicine,Recombinant Human Growth Hormones,Growth hormone,
...[+2]
Patent: 12
29
Western culture,TUTOR,Silicon carbide,
...[+2]
Patent: 11
30
Academic Training,Educational institution,Graduate degree,
...[+2]
Patent: 11
31
Patent: 11
32
Patent: 11
33
Patent: 11
34
National security,BCG vaccine,HIV vaccine,
...[+2]
Patent: 10
35
Medicine,Health care,Biosimilar,
...[+2]
Patent: 10
36
Patent: 10
37
Patent: 10
38
Academic Training,Educational institution,Graduate degree,
...[+2]
Patent: 10
39
Patent: 10
40
Patent: 10
41
Health care,Antibody,Medical laboratory,
...[+2]
Patent: 10
42
Patent: 10
43
Patent: 9
44
Patent: 9
45
Cell therapy,Pharmacy and Therapeutics,Epacadostat,
...[+2]
Patent: 9
46
Patent: 9
47
Patent: 9
48
Patent: 9
49
Patent: 8
50
Patent: 8
51
Patent: 8
52
Patent: 8
53
Patent: 8
54
Patent: 8
55
Patent: 8
56
Public university,Cancer immunotherapy,Medicine,
...[+2]
Patent: 8
57
Patent: 8
58
Patent: 7
59
Supervisor,Vocational education,Chemistry,
...[+2]
Patent: 7
60
Medicine,Health care,Active immunotherapy,
...[+2]
Patent: 7
61
Health care
Patent: 7
62
Patent: 7
63
Patent: 7
64
Patent: 6
65
Patent: 6
66
Patent: 6
67
Patent: 6
68
Patent: 6
69
Pinyin,Literature,Computer science,
...[+2]
Patent: 6
70
Patent: 6
71
Biotechnology,Ritonavir,Health care,
...[+2]
Patent: 6
72
Medicine,Diagnostic microbiology,Immunochemistry,
...[+2]
Patent: 6
73
Drug marketing,Square kilometer,Land area,
...[+2]
Patent: 6
74
Patent: 6
75
Patent: 6
76
Patent: 6
77
Patent: 5
78
Patent: 5
79
Biopharmaceutical,Drug,Health care,
...[+2]
Patent: 5
80
Patent: 5
81
International education,Biology,Medicine,
...[+2]
Patent: 5
82
Health care,Hospitality industry,Cancer immunotherapy,
...[+2]
Patent: 5
83
Management science,Square kilometer,Social science,
...[+2]
Patent: 5
84
Pinyin,Chemistry,Mathematics,
...[+2]
Patent: 5
85
Patent: 5
86
Patent: 5
87
Patent: 5
88
Patent: 5
89
Patent: 5
90
Patent: 5
91
Patent: 5
92
Patent: 5
93
Patent: 5
94
Patent: 5
95
Patent: 4
96
Patent: 4
97
Patent: 4
98
Patent: 4
99
Drug discovery,Health care,Contract research organization,
...[+2]
Patent: 4
100
Patent: 4
Page generation time: Jul 20 2025